These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5304322)

  • 1. Effects of chondroitin sulfates on serum lipids and hexosamines in atherosclerotic patients: with special reference to thrombus formation time.
    Izuka K; Murata K; Nakazawa K; Okubo K; Oshima Y
    Jpn Heart J; 1968 Sep; 9(5):453-60. PubMed ID: 5304322
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of chondroitin polysulphate on thrombus-formation and serum lipid levels.
    Murata K; Izuka K; Furuhashi T
    Experientia; 1969 Jun; 25(6):611-2. PubMed ID: 5800121
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the effectiveness of the treatment of arteriosclerosis].
    Bobkova VI; Mazurova SV; Fomchenkov SI
    Kardiologiia; 1974 Jul; 14(7):108-13. PubMed ID: 4431129
    [No Abstract]   [Full Text] [Related]  

  • 4. [Serum glycoproteins in coronary arteriosclerosis].
    Panaitescu G; Fica V; Tone P; Olteanu D
    Med Interna (Bucur); 1973 Aug; 25(8):929-35. PubMed ID: 4793913
    [No Abstract]   [Full Text] [Related]  

  • 5. The short-term effects of chondroitin sulfates A and C on coronary atherosclerotic subjects: With reference to its anti-thrombogenic activities.
    Nakazawa K; Murata K; Izuka K; Oshima Y
    Jpn Heart J; 1969 Jul; 10(4):289-96. PubMed ID: 4981320
    [No Abstract]   [Full Text] [Related]  

  • 6. Long term effects of chondroitin sulphates A and C on atherosclerotic subjects.
    Nakazawa K; Murata K
    Z Alternsforsch; 1975; 29(4):385-9. PubMed ID: 1210383
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of pectins on various indicators of lipid metabolism in patients with clinical symptoms of arteriosclerosis].
    Bartnikowska E; Michajlik A
    Kardiol Pol; 1980; 23(2):131-8. PubMed ID: 7382260
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of the effects of chondroitin sulfate isomers on atherosclerotic subjects.
    Nakazawa K; Murata K
    Z Alternsforsch; 1979; 34(2):153-9. PubMed ID: 395771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid abnormalities of atherosclerotic diseases in Chinese men.
    Ding YA; Chen D; Li YB
    Taiwan Yi Xue Hui Za Zhi; 1982 May; 81(5):559-67. PubMed ID: 6957543
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipid changes in serum following drug shock and intoxication.
    Murata K; Nakazawa K
    Tohoku J Exp Med; 1971 Jul; 104(3):225-32. PubMed ID: 5093546
    [No Abstract]   [Full Text] [Related]  

  • 11. The therapeutic effect of chondroitin polysulphate in elderly atherosclerotic patients.
    Nakazawa K; Murata K
    J Int Med Res; 1978; 6(3):217-25. PubMed ID: 648739
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on serum lipids in 199 arteriosclerotic subjects].
    Chiche P; Boigne JM; Haïat R
    Coeur Med Interne; 1967 Apr; 6(2):245-56. PubMed ID: 5618971
    [No Abstract]   [Full Text] [Related]  

  • 13. The biosynthesis of chondroitin sulphates. Influence of nucleotides and hexosamines on sulphate incorporation.
    ADAMS JB; RIENITS KG
    Biochim Biophys Acta; 1961 Aug; 51():567-78. PubMed ID: 13859335
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blood lipids and glucose tolerance in 100 patients with arteriosclerotic occlusions in the lower extremities].
    Beyrer K; May R; Sailer S
    Wien Klin Wochenschr; 1968 May; 80(20):392-4. PubMed ID: 5728030
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood lipids and atherosclerotic complications].
    Pries C; van Melsen JA; de Pagter HA; van Buchem FS
    Ned Tijdschr Geneeskd; 1967 Sep; 111(37):1593-7. PubMed ID: 6078638
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate.
    Baldoni E; Egge H; Cuttin S; Murawski U; Gibelli A; Giarola P
    Farmaco Sci; 1973 Sep; 28(9):713-21. PubMed ID: 4749857
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of long-term administration of clofibrate on the composition of blood lipids in patients with atherosclerosis.
    Poleszak J; Korolko A
    Pol Med J; 1972; 11(2):250-6. PubMed ID: 5071512
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipids and arteriosclerosis].
    Carmena R
    Rev Clin Esp; 1973 Aug; 130(3):181-94. PubMed ID: 4201566
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of studying blood serum lipid content for evaluating the nature of damage to major renal vessels].
    Lobova NM; Bavina MV; Arabidze GG
    Kardiologiia; 1971; 11(3):50-3. PubMed ID: 4397358
    [No Abstract]   [Full Text] [Related]  

  • 20. Compensatory mechanisms in erythrocyte lipids in patients with atherosclerosis.
    Michalak J; Kadziolka A; Pruszkowska R; Ledwozyw A; Madejczyk A
    Lipids; 1988 May; 23(5):476-80. PubMed ID: 3412128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.